Page last updated: 2024-08-24

epigallocatechin gallate and l-165041

epigallocatechin gallate has been researched along with l-165041 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Jian, JH; Juang, SJ; Lai, LP; Leu, JG; Liang, YJ; Liu, YC; Shyu, KG; Wang, BW	1

Other Studies

1 other study(ies) available for epigallocatechin gallate and l-165041

Article	Year
Advanced glycation end products-induced apoptosis attenuated by PPARdelta activation and epigallocatechin gallate through NF-kappaB pathway in human embryonic kidney cells and human mesangial cells. Diabetes/metabolism research and reviews, 2010, Volume: 26, Issue:5 Topics: Apoptosis; Catechin; Cell Survival; Cells, Cultured; Glycation End Products, Advanced; Humans; Interleukin-6; Kidney; Mesangial Cells; NF-kappa B; Oxidative Stress; Phenoxyacetates; PPAR delta; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Tumor Necrosis Factor-alpha	2010

Article

Year

Advanced glycation end products-induced apoptosis attenuated by PPARdelta activation and epigallocatechin gallate through NF-kappaB pathway in human embryonic kidney cells and human mesangial cells.

Diabetes/metabolism research and reviews, 2010, Volume: 26, Issue:5

Topics: Apoptosis; Catechin; Cell Survival; Cells, Cultured; Glycation End Products, Advanced; Humans; Interleukin-6; Kidney; Mesangial Cells; NF-kappa B; Oxidative Stress; Phenoxyacetates; PPAR delta; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Tumor Necrosis Factor-alpha

2010